ArticleCancers2025

CDK4/6 Inhibitors in Patients Aged 80 and Older with HR+/HER2- Metastatic Breast Cancer: A Real-World Multicenter Study.

Palma Fedele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.